Allopurinol Tablet
Sponsors
AstraZeneca, Assiut University, Arthrosi Therapeutics, Tanta University, Haiphong University of Medicine and Pharmacy
Conditions
Arthritis, GoutyChronic Kidney DiseaseCirrhoses, LiverCirrhosis, LiverDecompensated Cirrhosis of LiverDilated CardiomyopathyGoutGout Arthritis
Phase 1
Phase 2
Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
CompletedNCT05253833
Start: 2022-08-12End: 2024-10-28Updated: 2025-01-29
Allopurinol and Quality of Life in Liver Cirrhosis
CompletedNCT05828836
Start: 2022-06-15End: 2023-03-01Updated: 2023-10-31
Phase 4
HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness
Not yet recruitingNCT07369622
Start: 2026-01-20End: 2028-12-30Target: 228Updated: 2026-01-27
Role of Allopurinol in Prevention of Complications Related to Decompensated Cirrhosis of Liver
RecruitingNCT07800598
Start: 2025-09-10End: 2027-07-01Target: 54Updated: 2026-09-02